Rob Lutz

Rob Lutz

Former Chief Financial and Business OfficeratiBio· In proxies 2022–2023

Pay in FY2022iBio stock -82.5% the same year

Rob Lutz was paid $1.2M in FY2022 (Jun). iBio stock fell 82.5% that year.

Pay$100 in the stock at the end of FY21 → $17
Pay is from the Summary Compensation Table of each iBio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. iBioPublic company · 4 yr
    • Former Chief Financial and Business Officer2022 – Present · 4 yrStock in role -100%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?